ng-nitroarginine methyl ester has been researched along with Huntington Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fleming, A; Garcia-Arencibia, M; Imarisio, S; Korolchuk, VI; Kroemer, G; Luo, S; O'Kane, CJ; Renna, M; Rose, C; Rubinsztein, DC; Sarkar, S; Underwood, BR; Williams, A | 1 |
Deckel, AW; Freitas, R; Gary, KA; Gordinier, A; Kuwada, C; Nuttal, D; Tang, V | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Huntington Disease
Article | Year |
---|---|
Complex inhibitory effects of nitric oxide on autophagy.
Topics: Animals; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line; Class III Phosphatidylinositol 3-Kinases; Enzyme Inhibitors; HEK293 Cells; HeLa Cells; Humans; Huntingtin Protein; Huntington Disease; I-kappa B Kinase; Mechanistic Target of Rapamycin Complex 1; Membrane Proteins; Mice; Mitogen-Activated Protein Kinase 8; Multiprotein Complexes; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nuclear Proteins; Phosphorylation; Protein Isoforms; Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2011 |
Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression.
Topics: Animals; Behavior, Animal; Body Weight; Brain; Calcium-Calmodulin-Dependent Protein Kinases; Disease Models, Animal; Enzyme Inhibitors; Female; Huntington Disease; Immunohistochemistry; Male; Mice; Mice, Transgenic; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Tyrosine | 2001 |